Bashar H.H. Abuqayas MD

Hospital Medicine/Hospitalist

Clinical Assistant Professor of Internal Medicine

200 Hawkins DrIowa City, IA 52242

Dr. Abuqayas is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abuqayas' full profile Already have an account?

Summary

Bashar Abuqayas, MD, is an internal medicine specialist with a subspecialty in hospital medicine, based in Iowa City, IA. He completed his medical education in 2012 at the University of Jordan Faculty of Medicine. He has co-authored notable publications, including research on the clinical activity and safety of Cabozantinib published in JAMA Oncology, and a case report on Azacitidine-induced cryptogenic organizing pneumonia in the Journal of Medical Case Reports.

Education & Training

University of Jordan Faculty of MedicineClass of 2012

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IA State Medical License 2018 - 2028
FL State Medical License 2021 - 2023
NJ State Medical License 2016 - 2020
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the ...
Albert Jang, Tanya Jindal, Ali Raza Khaki, Cindy Y Jiang, Omar Alhalabi
Clinical Genitourinary Cancer. 2026-03-01
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder
The Oncologist. 2025-11-11
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.
Amanda Nizam, Charles B Nguyen, Jinju Li, Emily C Zabor, Pavlos Msaouel
Cancer Medicine. 2025-10-01